Don’t forget, we’re hosting our Accelerating Fellows Course in Boston tomorrow! Can’t attend but interested in finding out more about our medical education events? Contact the team at [email protected] to find out more about our full schedule of training programs coming up over the next few months! #NevroHFX #HFXiQ #NevroSIJoint #ChronicPain #Neuromodulation #medicaleducation
Nevro
Medical Equipment Manufacturing
Redwood City, California 66,512 followers
We Believe True Innovation Transforms More Lives
About us
Nevro is a global medical device company focused on delivering innovation to improve the quality of life for patients suffering from debilitating chronic pain. Through Nevro's pain management solutions, Nevro | HFX and Nevro | SI Joint, Nevro brings together enduring technologies, optimized therapies, and individualized patient support, all built on a foundation of proof that results in a comprehensive solution to relieve the burden of pain for more patients. HFX is a comprehensive solution that includes a Senza Spinal Cord Stimulation system and support services for the treatment of chronic pain, including painful diabetic neuropathy when programmed with a frequency of 10 kHz. Nevro | SI Joint includes the Nevro1™ SI joint fusion system with integrated transfixing technology provides immediate stabilization with opportunity for long-term fusion and pain relief through a posterior minimally invasive surgical (MIS) approach.
- Website
-
https://www.nevro.com
External link for Nevro
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Redwood City, California
- Type
- Public Company
- Founded
- 2006
Locations
-
Primary
1800 Bridge Parkway
Redwood City, California 94065, US
Employees at Nevro
Updates
-
We’re pleased to announce that Kerry Bradley our VP of Scientific Affairs is attending the Pacific Spine and Pain Society (PSPS) in Newport Beach today through Saturday. Today, Kerry spoke of our products, showcasing Nevro® HFX™ SCS Therapy and new SI Joint solutions. We are grateful that Kerry shared his valuable expertise and insights as a speaker at this year's event, representing Nevro with distinction and contributing to meaningful industry dialogue. #NevroHFX #HFXBigData #RealWorldOutcomes #ChronicPain #spinalcordstimulation
This content isn’t available here
Access this content and more in the LinkedIn app
-
We’re here at NSUKI 2024! We’ve got a schedule packed to the brim over the next few days including an educational reception tonight with Dr Ashish Shetty Alex Gilbert and Mark Duff, and presentation with Mr Nick Park and Dr Ashish Shetty tomorrow on how we’re harnessing the power of big data to drive patient care. Sophie Halliwell, VP & GM Commercial International and Claire Smith, VP Strategic Growth & Innovation from our senior leadership team will also be in attendance and available for meet and greets to talk about all the latest developments in our HFX Therapy™ Places are limited so to book any remaining sessions, pop along and speak to the Nevro team at the stand. #NevroHFX #HFXBigData #RealWorldOutcomes #ChronicPain #HFXAlgorithm #spinalcordstimulation #NSUKI2024
-
Nevro Fellow Education Continues in Dallas! This past weekend, we had an incredible time in Dallas, TX, as part of our 2024-2025 Fellow Education tour. At Nevro, we know how important hands-on training in Spinal Cord Stimulation (SCS) and SI Joint Fusion is for fellows, and we're committed to providing best-in-class education alongside our amazing faculty partners. A huge thank you to our dedicated faculty team, Drs. Eric Cornidez, Joseph DiChiara, Warren Grace III, M.D., Tim Ratino, Tolga Suvar, M.D., Chheany Ung, and Thomas White, MD for their passion and expertise! And, of course, a shout-out to the fellows who brought their energy and enthusiasm for learning! It’s inspiring to see the next generation of leaders in pain management coming together. We can't wait to meet the next group in Boston! #FellowEducation #MedEd #SCS #SIJointFusion #Nevro #FacultyShoutOut Courtney Carlson, Laurie Cigan, Jazzimen Perez, MS, Lisa Puzzuoli-Belcher, Tenaje Calloway, BSN, RN, Mary T. Consoles, Kasey Hazelton
-
Welcome to the relentless pursuit of optimal relief. Last week, we announced the launch of our groundbreaking HFX AdaptivAI™ powering HFX iQ™, and we're already seeing exciting results. Congratulations to Dr. Usman Latif for the first commercial use of HFX AdaptivAI technology, demonstrating the rapid impact of our innovation on patients' lives. Dr. Latif is instrumental in assisting Nevro in bringing this life-changing technology to patients. His dedication aligns with our vision of freeing patients from the burden of chronic pain. To hear more about his experience with HFX AdaptivAI please visit: https://lnkd.in/ggpbu2ph For additional safety information, please visit: https://lnkd.in/gVcSW7r2 #HFXAdaptivAI #HFXiQ #SpinalCordStimulation #ArtificialIntelligence #AI #ChronicPain #PainRelief
-
This International Pain Awareness Month we spent time with a number of healthcare professionals across the globe to ask them first hand how Nevro® HFX™ has helped change the way they treat patients. Scroll through our photo carousel to see what they had to say. Barani G Girish Vajramani, MCh, DNB, FRCS, FRCS Thorsten Luecke Dr. med. Bijan Cheikh Sarraf Merry Macdonald Discover more about Nevro® HFX™ Therapy at https://www.nevro.com/ #NevroHFX #ChronicPain #Neuromodulation #RealWorldOutcomes #ChronicPain #HFXAlgorithm #spinalcordstimulation #internationalpainawarenessmonth
-
Our Phase 2 of US Sales Excellence Training is a truly hands-on, memorable experience. Our Class 79 completed Phase 2 of their training, including a SI Joint lab in Dallas, Texas at the end of August. We would like to extend our gratitude to our training team, John Logeman, Heather Steffen, Jordonna Asbridge, for their continued dedication in driving excellence amongst our Sales staff. We’re excited to see this talented group of sales individuals putting their knowledge to use to help free patients from the burden of chronic pain and transform lives - one patient at a time. #Nevro #TeamTraining #Neuromodulation #NevroHFX #NevroSIJ
-
Join Us for an Exclusive Webinar one week from today! 🔊 Discover how Nevro1™ implant technology is revolutionizing SI Joint stabilization and fusion! Gain insights from industry experts on the all-in-one solution for rigid fixation and potential pain relief using a posterior minimally invasive surgical (MIS) approach. 📅 Date: October 2nd 🕐 Time: 7:30 PM EST 🔗 Register Here: https://lnkd.in/gvnUJ9XP #Nevro #Nevro1 #ChronicPain #SIJFusion
-
Today, we announced a major milestone with the launch of our new HFX AdaptivAI™, the only AI-driven technology in spinal cord stimulation. Combining insights from over 100,000 patients and more than 100 million data points, HFX AdaptivAI leverages artificial intelligence to deliver responsive and personalized pain relief in real-time. HFX AdaptivAI puts patients in control of their pain relief while, at the same time, providing physicians the ability to monitor their patient’s pain journey – closing the loop that matters. Learn more: https://lnkd.in/grpZGgwy #HFXAdaptivAI #HFXiQ #SpinalCordStimulation #ArtificialIntelligence #AI #ChronicPain #PainRelief
-
The Nevro MedEd team is excited to kick off the 2024-2025 Fellow's Education series this weekend in Las Vegas, NV! Over the next three weekends, we’ll be traveling to four cities, bringing this invaluable training to fellows across the country. 📅 Dates: Join us in Vegas on 9/21, Dallas and Atlanta on 9/28 and Boston on 10/5. This is the first of four hands-on training courses, where we will partner with leading faculty to provide advanced education on Spinal Cord Stimulation (SCS) and SI Joint Fusion. Interested in learning more or attending a program near you? Reach out to your local Nevro representative for details! #NevroMedEd #FellowsEducation #SCS #SIJointFusion #MedicalEducation #PainManagement #Training
Similar pages
Browse jobs
Stock
NVRO
NYSE
20 minutes delay
$4.97
0.02 (0.404%)
- Open
- 5.1
- Low
- 4.81
- High
- 5.126
Data from Refinitiv
See more info on